device launch

John Constantine, Senior VP at Orchestrall, Inc: How to Accelerate Drug and Device Launch in the Post-COVID World

New Era; New Launch Excellence Blueprint for 2021-2022

Episode 2: How to Accelerate Drug and Device Launch in the Post-COVID World

New Era; New Launch Excellence Blueprint for 2021-2022

ACTO Emerges as a Leader in Life Sciences Commercialization; Closes Strong Calendar Year 2018 with 184% Revenue Growth and Doubled Customer Base

ACTO Acquires Scrimmage

ACTO Acquires Scrimmage, Disrupting Life Sciences Learning and Engagement Market

How Life Sciences Companies Can Level Up Healthcare Education in Post-COVID Era

The Ultimate Guide to Omnichannel Education

ACTO Named One of the 2019 PM360 ELITE 100

New Era; New Launch Excellence Blueprint for 2021-2022

Life Sciences’ Transformative Journey to Consolidation in 2021 and What to Expect in 2022

Four Fundamentals for Telling Your Clinical Evidence Story

ACTO Achieves 158% Year to Date Revenue Growth in 2019 and Has Digitally Transformed Over 50 Life Sciences Companies

Episode 7: How is Technology Reshaping the Medical Device Industry?
Fighting the Forgetting Curve: The Life Sciences Trainer’s Guide to Microlearning

My Firsthand Experience with ACTO’s Microlearning, as a Learner

ACTO Wins Gold Stevie® Award in the Cloud Platform Category in 2019 International Business Awards

Channel Partners: Gaining Visibility and Creating Accountability

Channel Partners: Accessibility is the Magic Word

When the Rubber Meets the Road, Don’t Slip


Critical Insights from Industry Leaders for Successful Implementation of Commercial Digital Transformation
ACTO Appoints Jenny Yeung as Chief Financial Officer

Exclusive ACTO Omnichannel Platform Mini Demo

Omnichannel Education For The Life Sciences
ACTO launches LAICA, the first AI-powered conversational assistant for Life Sciences learning

ACTO Earns Gold at Brandon Hall Technology Awards 2021

ACTO Kicks Off 2021 with Chart-Topping Growth


What Does ACTO’s Acquisition of CoHealth Mean for Patient Education?

ACTO Integrates Life Sciences Education Platform with Veeva CRM

Implementation Blueprint for Omnichannel Education
Rapid Reskilling in an Ever-Changing Landscape

For Our Customers: COVID-19 Response Series

ACTO Bolsters Executive Management Team to Meet Significant US Commercial Growth

The LTEN Learning Journey with Kathleen Herndon & Dawn Brehm
Digital Transformation Ideals of Change – Prescription for Pharma and Medical Device Trainers for Rapid Reskilling

ACTO Closes $11.5M Series A Round to Accelerate Virtual Transformation for Life Sciences Companies

ACTO Acquires CoHealth to Open New Frontier in Patient Education

The Triple A Initiative: ACTO, Axiom, and AstraZeneca

The Triple A Initiative: ACTO, Axiom, and AstraZeneca

Episode 3: The New Model for Crisis Leadership in Life Sciences
Selling on Clinical Value – Action Plan
